Jonathan Anderman - 11 Feb 2025 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMPX	Stock Option (Right to Buy)	Award	$0	+280,000		$0.000000	280,000	11 Feb 2025	Common Stock	280,000	$3.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options vest over 48 substantially equal monthly installments starting March 11, 2025.